Kornitzer Capital Management Inc. KS trimmed its holdings in Agilent Technologies Inc (NYSE:A) by 22.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 262,330 shares of the medical research company’s stock after selling 77,645 shares during the quarter. Kornitzer Capital Management Inc. KS owned approximately 0.08% of Agilent Technologies worth $17,697,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of A. Advisors Asset Management Inc. grew its position in Agilent Technologies by 10.0% in the 4th quarter. Advisors Asset Management Inc. now owns 25,498 shares of the medical research company’s stock valued at $1,720,000 after acquiring an additional 2,311 shares during the last quarter. Harvey Investment Co. LLC grew its position in shares of Agilent Technologies by 2.4% during the 4th quarter. Harvey Investment Co. LLC now owns 107,695 shares of the medical research company’s stock worth $7,265,000 after buying an additional 2,475 shares in the last quarter. First Manhattan Co. grew its position in shares of Agilent Technologies by 1.9% during the 4th quarter. First Manhattan Co. now owns 70,479 shares of the medical research company’s stock worth $4,754,000 after buying an additional 1,345 shares in the last quarter. Keybank National Association OH grew its position in shares of Agilent Technologies by 14.4% during the 4th quarter. Keybank National Association OH now owns 12,672 shares of the medical research company’s stock worth $855,000 after buying an additional 1,592 shares in the last quarter. Finally, Pendal Group Ltd grew its position in shares of Agilent Technologies by 17,076.7% during the 4th quarter. Pendal Group Ltd now owns 1,227,965 shares of the medical research company’s stock worth $71,925,000 after buying an additional 1,220,816 shares in the last quarter.
A stock opened at $75.80 on Monday. The company has a current ratio of 3.29, a quick ratio of 2.74 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $24.08 billion, a P/E ratio of 27.17, a PEG ratio of 2.12 and a beta of 1.33. Agilent Technologies Inc has a 12-month low of $60.42 and a 12-month high of $76.69.
Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 19th. The medical research company reported $0.81 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.74 by $0.07. The firm had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.26 billion. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. Agilent Technologies’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.67 EPS. On average, research analysts expect that Agilent Technologies Inc will post 3.04 EPS for the current year.
Agilent Technologies declared that its Board of Directors has authorized a stock repurchase program on Monday, November 19th that permits the company to repurchase $1.75 billion in outstanding shares. This repurchase authorization permits the medical research company to purchase up to 8.8% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s management believes its stock is undervalued.
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 23rd. Investors of record on Monday, December 31st were given a $0.164 dividend. The ex-dividend date was Friday, December 28th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.87%. Agilent Technologies’s dividend payout ratio is 23.66%.
In other news, CEO Michael R. Mcmullen sold 15,923 shares of the firm’s stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $73.20, for a total transaction of $1,165,563.60. Following the sale, the chief executive officer now owns 492,546 shares in the company, valued at $36,054,367.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,500 shares of the firm’s stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $71.06, for a total value of $106,590.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 43,816 shares of company stock valued at $3,242,727.
A number of brokerages recently weighed in on A. Alembic Global Advisors downgraded Agilent Technologies to a “hold” rating in a research report on Monday, December 31st. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $79.00 price objective for the company in a research note on Monday, January 21st. Needham & Company LLC assumed coverage on Agilent Technologies in a research report on Wednesday, January 2nd. They set a “buy” rating and a $77.00 price target for the company. Cleveland Research lowered Agilent Technologies from a “buy” rating to a “neutral” rating in a report on Monday, November 12th. Finally, ValuEngine raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, November 2nd. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $81.17.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
See Also: Float
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.